Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

InfuSystem Holdings, Inc (INFU)

$9.12 +2.59% NYSE: INFU · 15-min delayed
  • ROCHESTER HILLS, Michigan
  • Public · NYSE: INFU
  • 473 employees
$186.5MMarket cap
$143.4MRevenue · FY2025
$6.6MNet income
473Employees
INFUNYSE
1992IPO

About InfuSystem Holdings, Inc

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$143.4M
Net income
$6.6M
Total assets
$100.6M
Market cap
$186.5M
Gross margin
56.0%
Operating margin
8.3%
Net margin
4.6%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$143.4M
Cost of revenue
$63.1M
Gross profit
$80.3M
Operating expenses
$68.4M
Operating income
$11.9M
Income tax
$4.0M
Net income
$6.6M
EPS (basic)
$0.32
EPS (diluted)
$0.31

Balance sheet

Total assets
$100.6M
Current assets
$36.3M
Total liabilities
$43.2M
Current liabilities
$20.2M
Shareholders’ equity
$57.3M

Cash flow

Operating cash flow
$24.4M
Investing cash flow
-$6.8M
Financing cash flow
-$15.0M
Net cash flow
$2.7M

Statements via Polygon.io (SEC filings)

NYSE: INFU
$9.12 +2.59%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$5.41 $10.79

52-week range

Market cap
$186.5M
P/E ratio
29.4
EPS (diluted)
$0.31
Shares outstanding
20.4M
Open
Day range
Prev close
Volume
IPO date
Dec 22, 1992

InfuSystem Holdings, Inc (INFU) Stock Price

  • Profitable — net income of $6.6M in FY2025.
  • Revenue grew 40% from FY2021 to FY2025.
  • Gross margin of 56.0%, net margin 4.6%.
  • Trading 15% below its 52-week high.
  • Valued at a price-to-earnings (P/E) ratio of 29.4.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review InfuSystem Holdings, Inc.

Write a review
Newsroom

News about InfuSystem Holdings, Inc

News & sentiment via Polygon.io

FAQ

InfuSystem Holdings, Inc: frequently asked questions

Is InfuSystem Holdings, Inc an American company?

InfuSystem Holdings, Inc is a US-based company headquartered in Rochester Hills, Michigan, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is InfuSystem Holdings, Inc headquartered?

InfuSystem Holdings, Inc is headquartered in Rochester Hills, Michigan, United States.

Is InfuSystem Holdings, Inc publicly traded?

Yes — InfuSystem Holdings, Inc is a publicly traded company. Its stock trades under the ticker symbol INFU on the NYSE.

What does InfuSystem Holdings, Inc do?

InfuSystem Holdings, Inc is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →